MedicarePartD.guide

A non-government resource built from CMS public data

Hadlima on HealthSpring Assurance Rx (S5617-013)

adalimumab-bwwd

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 4.8 per 28 days.

$772.69
Patient pays / month, after deductible
$1,233.94
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

HADLIMA 40 mg/.8mL Solution at a preferred retail pharmacy, from the plan's negotiated price of $3,090.76 for a month. Other covered strengths are listed below.

Prior authRequired on all 4 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
FormTierPatient pays / monthLimits
HADLIMA 40 mg/.8mL Solution5$772.69PA · 4.8 per 28 days
HADLIMA 40 mg/.8mL Solution5$772.69PA · 4.8 per 28 days
HADLIMA 40 mg/.4mL Solution5$865.31PA · 2.4 per 28 days
HADLIMA 40 mg/.4mL Solution5$862.19PA · 2.4 per 28 days

Other TNF blockers on this plan

Verify with the plan before prescribing or filling. Member services: (800)222-6700. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5617-013